
Antiviral Drugs for Influenza in 2023-2024 - 1 AMA PRA Category 1 Credits™
Learn about the latest advancements in antiviral drugs for Influenza in 2023-2024. Explore cutting-edge treatments in this timely course.

About this course
Influenza, commonly known as the flu, is a prevalent respiratory illness with the potential for severe complications. While it is often a self-limited condition, certain individuals face an elevated risk of complications such as pneumonia, respiratory failure, and even death. The 2023–2024 influenza season brings forth key recommendations for both treatment and prevention, including the use of specific antiviral drugs and the importance of vaccination.
Course Accreditation
Instructors

John Francis Villa, MD, FACEP, FAAFP is an Emergency Medicine Specialist in Florida with more than 25 years in emergency medicine and family medicine.
You might also be interested in

Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional
2 hours
The Growing Prevalence of Breast Cancer among Adolescents, Young Adults, and People of Color
1 hourSee why 500k+ healthcare professionals trust us with their renewal
Real reviews, real results
Get total access with AchieveCE
Get unlimited CE for one low annual fee. Save time and money by becoming a member.
